Evaluating the SARS-CoV-2
Specific Antibodies in Saliva
Siyang Yu1,2*, Peiyan Zhang3*,
Mingfeng Liao1, Juanjuan Zhang1,
Suisui Luo4, Jinglei Zhai4, Yaxi
Zhang1, Jingyan Lin1, Jing
Yuan3, Zheng Zhang1,5, Fuxiang
Wang3, Lanlan Wei1,2
1. Institute of Hepatology, National Clinical Research Center for
Infectious Disease, The Third People’s Hospital of Shenzhen, Second
Hospital Affiliated to Southern University of Science and Technology,
Shenzhen, Guangdong, China
2. Microbiology Department, Harbin Medical University, Harbin,
Heilongjiang, China
3. Department of Infectious Diseases, The Third People’s Hospital of
Shenzhen, Second Hospital Affiliated to Southern University of Science
and Technology, Shenzhen, Guangdong, China.
4. School of Medicine, Southern University of Science and Technology,
Shenzhen, Guangdong, China.
5. Shenzhen Research Center for Communicable Disease Diagnosis and
Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong,
China.
* These authors contributed equally to this work.